Similarly, BRAF mutation was associated with the expression of CSC markers, and advanced cancer stage and metastasis, and BRAF inhibitors induce epithelial re-differentiation in human CRC cell lines [53,54]. Here, BRAF is linked to colorectal carcinoma.